期刊
VACCINE
卷 20, 期 -, 页码 S32-S37出版社
ELSEVIER SCI LTD
DOI: 10.1016/S0264-410X(01)00287-0
关键词
respiratory syncytial virus (RSV); parainfluenza virus (PIV); vaccines
资金
- NIAID NIH HHS [N01-AI-65298] Funding Source: Medline
- NICHD NIH HHS [HD36311] Funding Source: Medline
- NIDCR NIH HHS [DE14039] Funding Source: Medline
Development of an RSV vaccine for infants has been hindered by the lack of an ideal animal model that exhibits disease, and the challenge of effectively immunizing very young infants who are immunologically immature. Nevertheless, significant progress has been made recently in developing live attenuated viruses and protein subunit vaccine candidates. Numerous vaccine candidates are currently in early clinical trials. This paper reviews the significant obstacles to development of RSV vaccines, and the progress made to date. (C) 2001 Elsevier Science Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据